Summary : HYFTOR™ is the first topical treatment approved by the FDA for facial angiofibroma in…
Monthly Archives
April 2022
-
-
Summary : The Venus VivaTM will now make its American premiere, having already established itself…
-
Global MarketPatent infringementPatents
FMC Corporation Wins Patent Infringement Case Against Udragon for Chlorantraniliprole
by adminSummary : The Hangzhou Intermediate People’s Court in Zhejiang Province, China, awarded FMC a permanent…
-
Summary: EPSOLAY (benzoyl peroxide, cream, 5%) utilizes Sol-Gel’s proprietary microencapsulation technology for the treatment of…
-
Covid DrugsGileadU.S FDA
Gilead’s Veklury Becomes the First FDA-approved COVID-19 Treatment for Infants
by adminSummary : The first treatment for COVID-19 in young children has been approved by the…
-
Summary : Piramal Enterprises said in a regulatory filing on Wednesday that its subsidiary Piramal…
-
Alembic PharmaMerger / Acquisition
Alembic Pharma acquires 100% stake in Aleor Dermaceuticals
by adminSummary : The company has acquired remaining 40 per cent stake from Orbicular Pharmaceutical Technologies,…
-
Dr. Reddy`sIndiaMerger / AcquisitionNovartis
Dr. Reddy’s will Pay Rs 463 Crore for Novartis’ Cardiovascular Drug Cidmus (Valsartan +Sacubitril)
by adminSummary Dr Reddy’s Laboratories, an Indian generic pharmaceutical company, has agreed to pay $61 million…
-
Summary : AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein…
-
U.S FDA
Alymsys® (Bevacizumab-maly), a Biosimilar of Bevacizumab developed by mAbxience, has been Approved by the FDA.
by adminSummary : ALYMSYS® was developed by mAbxience, a global biotech company with over a decade of…
Newer Posts